Survival advantage of lanthanum carbonate for hemodialysis patients with uncontrolled hyperphosphatemia

Abstract

Treatment with lanthanum was independently associated with a significant survival benefit in hemodialysis patients with inadequately controlled hyperphosphatemia. Further studies are required to confirm these findings.